[Fibrate in lipid metabolism disorders]

Pharm Unserer Zeit. 2007;36(2):114-9. doi: 10.1002/pauz.200600209.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Atherosclerosis / prevention & control
  • Clofibric Acid / therapeutic use*
  • Diabetes Complications / drug therapy
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Lipid Metabolism Disorders / complications
  • Lipid Metabolism Disorders / drug therapy*

Substances

  • Hypolipidemic Agents
  • Clofibric Acid